BiomX Inc

BiomX Inc (PHGE) Financials

$0.138

+0.006 (+4.69%)At close

PHGE Comparative Benchmarking

In the context of the broader market, PHGE competes directly with industry leaders such as CLDI and TCRT. With a market capitalization of $3.70M, it holds a significant position in the sector. When comparing efficiency, PHGE's gross margin of N/A stands against CLDI's N/A and TCRT's N/A. Such benchmarking helps identify whether BiomX Inc is trading at a premium or discount relative to its financial performance.

BiomX Inc Financial Performance

The company has shown a troubling trend with net income losses increasing each quarter, culminating in a loss of -19,225,000 in Q1 2026. The current ratio has dropped to 1.24, indicating potential liquidity issues.

Financials

FY2026Q2
332.00K
Total Revenue
FY2026Q2
YoY:
-27.16%
-5.41M
Operating Profit
FY2026Q2
YoY:
-36.29%
-3.85M
Net Income after Tax
FY2026Q2
YoY:
-89.89%
-0.37
EPS - Diluted
FY2026Q1
YoY:
-37.86%
-5.41M
Free Cash Flow

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started